Oruka Therapeutics, Inc. Shareholders' Equity
Oruka Therapeutics, Inc. (ORKA) had Shareholders' Equity of $1.11 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.11B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $486.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $471.93M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $486.79M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.11B 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $486.72M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $471.93M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $486.79M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $343.64M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $364.73M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $382.22M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $342.37M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$28.98M 10-Q · filed 2025-11-12 | $32.57M 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$7.06M 10-Q · filed 2025-11-12 | $35.13M 10-Q · filed 2024-04-25 |
| 2024-02-06 | $1.00K 10-K · filed 2026-03-12 | |
| 2024-02-05 | $1.00K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $37.02M 10-Q · filed 2024-08-01 | |
| 2023-09-30 | $37.97M 10-Q · filed 2024-08-01 | |
| 2023-06-30 | $39.24M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | $40.53M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $41.67M 10-Q · filed 2024-08-01 | |
| 2022-09-30 | $42.73M 10-Q · filed 2023-10-18 | |
| 2022-06-30 | $44.96M 10-Q · filed 2023-10-18 | |
| 2022-03-31 | $47.94M 10-Q · filed 2023-10-18 | |
| 2021-12-31 | $51.04M 10-K · filed 2024-02-01 | |
| 2021-09-30 | $56.60M 10-Q · filed 2022-10-28 | |
| 2021-06-30 | $61.21M 10-Q · filed 2022-10-28 | |
| 2021-03-31 | $65.91M 10-Q · filed 2022-10-28 | |
| 2020-12-31 | $46.52M 10-K · filed 2023-02-24 | |
| 2020-09-30 | $50.45M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $10.30M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $6.31M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $7.61M 10-K · filed 2022-03-14 | |
| 2019-09-30 | $8.80M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $9.19M 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $7.32M 10-Q · filed 2020-11-02 | |
| 2018-12-31 | $6.03M 10-K · filed 2021-03-18 | |
| 2018-09-30 | $7.46M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $9.00M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $11.05M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $10.28M 10-K · filed 2020-02-18 | |
| 2017-09-30 | $14.35M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $14.75M 10-Q · filed 2018-11-14 | |
| 2017-03-31 | $18.04M 10-Q · filed 2018-11-14 | |
| 2016-12-31 | $22.19M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $26.48M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $30.89M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $34.58M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $38.07M 10-K · filed 2018-03-22 | |
| 2015-09-30 | $41.09M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $43.76M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $12.13M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $14.74M 10-K · filed 2017-03-21 | |
| 2014-09-30 | $17.20M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $19.32M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $21.53M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $15.58M 10-K · filed 2016-03-17 | |
| 2013-09-30 | $18.37M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $20.03M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $3.31M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $2.91M 10-K · filed 2015-03-19 | |
| 2012-09-30 | $3.18M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $3.29M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $4.36M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $5.73M 10-Q · filed 2014-05-13 | |
| 2011-09-30 | $5.73M 10-Q · filed 2012-08-13 | $5.81M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $7.54M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $6.77M 10-Q · filed 2014-05-13 | |
| 2009-12-31 | $7.41M 10-Q · filed 2014-05-13 | |
| 2008-12-31 | -$38.18M 10-Q · filed 2014-05-13 | |
| 2007-12-31 | -$19.69M 10-Q · filed 2014-05-13 | |
| 2006-12-31 | -$5.74M 10-Q · filed 2014-05-13 | |
| 2005-12-31 | -$678.00K 10-Q · filed 2014-05-13 | |
| 2004-12-31 | -$619.00K 10-Q · filed 2014-05-13 | |
| 2003-12-31 | -$115.00K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |